Clinical trial
Gene Therapy for Pleural Malignancies
NCT00299962 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00299962 |
|---|---|
| Title | Gene Therapy for Pleural Malignancies |
| Official title | A Phase I Clinical Trial of Repeated Dose Intrapleural Adenoviral-Mediated Interferon-beta (BG00001, Ad.hIFN-β for Pleural Malignancies |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Cancer Institute (NCI) NIH Biogen Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pleural Mesothelioma, Metastatic Pleural Effusions |
| Intervention type | Biological |
| Interventions | Adenoviral-mediated Interferon-beta, SCH 721015 |
| Enrollment | 17 |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Oct 1, 2009 |
| First posted | Mar 7, 2006 |
| Last update posted | Mar 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: